System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Giuseppe Carrà, MD, PhD is an expert in Psychiatry at University of Milano-Bicocca (Italy). Giuseppe Carrà has authored 322 publications, the most recent in 2026, and is an investigator in 3 clinical trials, 2 of them ongoing. SLR score: 1,014 (community average: 125). How the SLR is computed.

LeadR Profile

Giuseppe Carrà, MD, PhD University of Milano-Bicocca Italy
1 014 ScienceLeadR Reputation 1014

Unlock

Register Login
Network Map

Psychiatry

Subspecialties: Public Health - Neurology - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1995 - 2026
Source: PubMed

University of Milano-Bicocca

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 322

Citations

Citations: 10 448 1st author: 47 Last author: 114 Unique author: 1

Main journals

Eur Psychiatry 17
Eur Arch Psychiatry Clin Neurosci 10
Epidemiol Psichiatr Soc 9
Front Psychiatry 9
J Psychiatr Res 8

Best Journals

World Psychiatry 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Complete blood count-derived inflammatory markers in schizophrenia: towards an integrated framework.
PMID 42799901 — blood, schizophrenia, nervous system diseases, neurology, psychiatry		Eur Arch Psychiatry Clin Neurosci20260
Complete blood count-derived inflammatory markers and symptom phenotypes in schizophrenia spectrum disorders: A hierarchical clustering analysis.
PMID 42320354 — monocytes, blood, lymphocytes, phenotype, schizophrenia, cluster analysis		Schizophr Res20261
Clinical and Sociodemographic Correlates of Poor Medication Adherence in People With Bipolar Disorder: A Systematic Review and Meta-Analysis.
PMID 42267732 — bipolar disorder, medication adherence, generalized anxiety disorder		Bipolar Disord20260
Efficacy of sertraline combined with low-dose antipsychotics in first-episode schizophrenia.
PMID 41882386 — schizophrenia, antipsychotic agents, sertraline, nervous system diseases, neurology, psychiatry		Eur Arch Psychiatry Clin Neurosci20260
Risk and protective factors against burnout increase during psychiatry training: evidence from a longitudinal multicentre controlled study.
PMID 41867012 — emotions, education, professional, protective factors, burnout, psychological, psychiatry, emotional regulation		Br J Psychiatry20260

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1
Phase 3 1
Phase 4 1

By status:

Active not recruiting 1
Completed 1
Recruiting 1

By type:

Interventional 3

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 1
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A study to measure how well seltorexant works in adult depressed patients and how safe it is both for short and long term use when taken with another antidepressant
2023-509070-36-00 — antidepressive agents, safety, maintenance, signs and symptoms, depressive disorder, aged, therapeutics, sleep initiation and maintenance disorders, depressive disorder, major		Phase 3Recruiting2025
Social Participation and Healthy Aging
NCT06162871 — pilot projects, pilots, computers, aging, computer literacy, healthy aging, psychosocial intervention, literacy		N/AActive not recruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS